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Abstract: 
Objections to the use of topical nasal anesthesia (TNA) during fiberoptic endoscopic evaluation of 
swallowing (FEES) with sensory testing (FEESST) have been raised, primarily because of the possibility of 
desensitizing the pharyngeal and laryngeal mucosa and affecting both the sensory and motor aspects of the 
swallow. Furthermore, it has been suggested that TNA is not necessary during FEES as it does not improve 
patient comfort or make the procedure easier for the endoscopist. The purpose of this double-blind, 
randomized, controlled, crossover clinical trial was to determine how gel TNA during flexible endoscopic 
evalu- ation of swallowing with sensory testing affects sensation, swallowing, and comfort rating scores in 
healthy nondys- phagic participants. Laryngopharyngeal sensory thresholds and swallowing  durations  were  
compared  between two conditions: TNA and sham. Transition duration decreased statistically significantly 
during the TNA condition com- pared to the sham for 10 ml only (p \ 0.05). All other swallowing measures 
did not change between the conditions. Laryngopharyngeal sensory thresholds and perceptions did not 
change between conditions. No change was observed for subject comfort scores, ease of exam, or quality of 
view. Future studies should evaluate TNA administration vari- ables, including concentration, dosage 
amount, and method of application, to determine the optimal strategy for pro- viding comfort while 
avoiding altered swallowing. 
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Introduction 
FEES and FEESST 
First introduced in the late 1980s, fiberoptic endoscopic 
evaluation of swallowing (FEES) is now a standard 
assessment procedure in hospitals across the United States 
and in many other countries. Due to technological advan- 
ces, FEES units can now fit into a suitcase, and private 
practices are sprouting up to provide FEES in nursing 
homes and rehabilitation centers where patients would 
otherwise have to be transferred somewhere else for 
assessment or not receive one. Although videofluoroscopy 
has historically been considered the gold standard of dys- 
phagia instrumental assessment procedures [1, 2], FEES 
has secured its status alongs ide videofluoroscopy as a 
reliable and sensitive assessment tool for many aspects of 
swallowing function, and videofluoroscopy units do not fit 
into suitcases! 
FEES was first described by Langmoreet al. [3] in 1988 
and subsequently by others as fiberoptic visualization of 
the laryngopharyngeal area during the ingestion of colored 
food items to determine the presence of dysphagia and 
define treatment options [4–6]. Upon its introduction, 
research quickly and exponentially began to proliferate. 
After all, the tools were already available in most ENT 
clinics, and the possibility of assessing swallowing without 
irradiating patients was appealing. Research has shown that 
FEES is safe to use serially [7], making it most useful for 
ongoing management of dysphagic patients as they pro- 
gress with therapy, and a viable option for biofeedback [8]. 
Researchers can feel secure using FEES to collect swal- 
lowing data as the presence of the endoscope in the phar- 
ynx does not alter swallowing physiology [9] and FEES is 
reliable to use with the penetration-aspiration scale (PAS) 
[10, 11]. 
Aviv et al. [12] were the first to describe using calibrated 
pulses of air delivered from the tip of the endoscope to 
psychophysically test laryngopharyngeal sensation. In this 
manner they were able to assign a numerical air pressure 
value to each patient’s laryngopharyngeal sensation 
threshold. This group later described the use of this same 
technique for delivering air pulses to the aryepiglottic folds 
to elicit a brief, involuntary closure of the vocal cords, 
which can be visualized from the FEES monitor [13]. This 
closure, a protective mechanism against aspiration, is the 
laryngeal adductor reflex (LAR) [14, 15]. LAR threshold 
testing yields sensory thresholds similar to those of psy- 
chophysical testing, but it does not require a verbal or 
physical response from the testee and is therefore a more 
objective manner with which to measure laryngeal sensa- 
tion [16]. When a FEES examination is combined with air 
pulse sensory testing it is called fiberoptic endoscopic 
evaluation of swallowing with sensory testing (FEESST). 
has shown that sensory input and feedback provided by 
central mechanisms during swallowing are vital to the 
initiation, implementation, and modulation of the reflexive 
motor programming planned by the brainstem and exe- 
cuted by the cranial nerves. The internal branch of the 
superior laryngeal nerve (ISLN) provides afferent inner- 
vation to the supraglottic structures, and stimulation of the 
ISLN can cause laryngeal closure [21], induce swallowing 
movements [22],  and cause central apnea [23]. Studies 
involving anesthetizing the oropharynx have shown that 
sensory interruption can result in dysfunction of the normal 
swallow [24, 25]. 
Using TNA During FEES/FEESST 
Considering the role of sensation in the swallowing pro- 
cess, it is imperative that clinicians choosing to employ 
TNA during nasendoscopy do so in a manner that does not 
disrupt the sensory or motor components or induce sec- 
ondary reactions to the anesthetic. At the location of 
application, topical anesthetics temporarily interrupt 
peripheral nerve impulses, effectively reducing or elimi- 
nating sensation [26]. It has been recommended that TNA 
be applied only to the nasal passages and not the pharynx 
during FEES, and to avoid the use of anesthetic sprays as 
they may lead to postnasal drainage of the anesthesia into 
the pharynx [17, 18]. While Langmore [18] recommends 
using 2 % viscous lidocaine (lignocaine), many other types 
of TNA are reportedly being used during FEES, including 
tetracaine, cocaine, benzocaine, xylocaine, and prilocaine 
[26]. Topical anesthesia can cause adverse reactions if US 
FDA recommendations are not followed as to proper usage 
and dosage. Allergic reactions to topical anesthesia are rare 
and account for only 1 % of all reactions [18]. 
Several studies have examined the utility of topical 
anesthetics, vasoconstrictors, and combinations of anes- 
thetics and vasoconstrictors for improving patient comfort 
level during nasendoscopy. Ten studies that assessed 
nasendoscopic pain treatment included a control treatment 
(saline or no treatment) and were therefore able to address 
efficacy [19, 20, 27–34]. Of these ten studies that focused 
on the efficacy of prenasendoscopic treatment for patient 
comfort, one recommended using a vasoconstrictor alone 
instead of TNA, three recommended using TNA, and five 
recommended using no treatment. All three studies that 
advocated TNA were either crossover or split-body 
designs, meaning each participant was compared to himself 
and therefore the results are more reliable. Two of the five 
studies that recommended no treatment used a lubricant on 
the endoscope; thus, it is reasonable to assume that the 
suggested alternative treatment of those studies is the use 
of lubricant jelly to ease passage of the scope through the 
nasal passages.  Two studies specifically on the use of 
Topical Nasal Anesthesia During FEES and FEESST 
Many clinicians utilize topical anesthetics to help reduce the 
discomfort and anxiety associated with a nasendoscopic 
exam. ASHA guidelines state that clinicians may choose to 
use topical nasal anesthetic (TNA) with or without vasocon- 
striction during nasendoscopy [17]. Some concerns about the 
use of TNA, especially during swallowing examinations, have 
been raised, primarily the possibility of the anesthetic dripping 
into the oropharynx or laryngopharynx and desensitizing the 
mucosa and potentially affecting both the sensory and the 
motor aspect of the swallow [17, 18]. Moreover, it has been 
suggested that TNA is not necessary during an endoscopic 
exam as it does not improve patient comfort and may make the 
experience worse because of its unpleasant taste [19, 20]. 
The argument against potentially desensitizing the 
laryngopharynx during swallowing is formidable. Research 
endoscope lubrication during nasendoscopy have been 
completed [35, 36]. 
A study by Butler et al. [28] specifically addressed the 
effects of the anesthetic on swallowing function. They 
reported anesthetized swallows were less safe and had 
higher PAS scores but were also more comfortable and led 
to greater tolerance of the procedure. However, they did use 
1 cc of 4 % liquid lidocaine in spray form prior to FEES on 
swallowing safety and patient tolerance compared to no 
treatment in the same participants [28]. The authors are 
currently evaluating whether lower doses of lidocaine can 
still provide comfort without compromising the swallow. 
Although some of the above-mentioned studies reported 
that no anesthesia is necessary during nasendoscopy and 
may, in fact, affect swallowing, many clinicians continue to 
use TNA based on personal experience or patient request. 
Moreover, the few extant data reporting an effect of TNA on 
swallowing function were reported after a sprayed appli- 
cation of TNA. The primary method of administering TNA 
clinically for FEES is to apply gel TNA directly to the nares 
using a cotton-tip applicator; this is the method described in 
the originally published FEES protocol [18]. There is cur- 
rently no evidence that the use of gel TNA during clinical 
FEES or FEESST would affect either swallowing physiol- 
ogy or the sensation of the laryngopharynx. 
The aim of this study was to determine how 0.4 ml of 
viscous (gel) TNA applied at the onset of FEESST affects 
the sensory and motor aspects of swallowing in healthy 
nondysphagic participants. This specific amount (0.4 ml) 
was chosen as this is approximately the maximum amount 
that can be inserted into the nares using a cotton-tip 
applicator two times. This study was a prospective, double 
blind, controlled, randomized, crossover study of subjects 
who underwent FEESST twice: once in a topically anes- 
thetized condition (2 % viscous lidocaine) and once in a 
placebo condition (Surgilube, Savage Laboratories, Mel- 
ville, NY, USA). 
secondary to discomfort (1). A total of 36 participants (33 
females) completed the study (age range = 18–38 years; 
mean = 23.16). All participants signed a written informed 
consent and were given the opportunity to ask questions 
about the study before it began. Participants were screened 
prior to signing the informed consent and were excluded only 
if they had a past or current history of neurological disease, 
thyroid problems, head and neck cancer, swallowing prob- 
lems, uncontrolled gastroesophageal reflux disease, or milk 
allergy. 
Design 
Participants underwent nasendoscopic testing on two sep- 
arate days under two conditions. In the experimental con- 
dition, 0.4 ml of 2 % viscous lidocaine hydrochloride was 
applied to one side of the nasal cavity twice, one minute 
each time, via a cotton-tip applicator. This is well below 
the maximum dosage recommendation of 2 mg per pound 
of body weight, and 2 % lidocaine is concentrated at 20 
mg/ml, which means that a 100-pound person can safely 
have 10 ml of 2 % viscous lidocaine [26]. In the sham 
condition, 0.4 ml of Surgilube was applied to one side of 
the nasal cavity twice via a cotton-tip applicator. The same 
nasal cavity was used in both conditions and was selected 
based on patency. The left nostril was chosen for 22/36 
(61 %) participants and the right for 14/36 (39 %) partic- 
ipants. The conditions were given in a double-blind fashion 
so that neither the subject nor the tester knew which agent 
was being used. 
Participants were seated upright in a standard size 
cushioned chair with a back. While no one but the partic- 
ipant and the coinvestigator were in the room, the coin- 
vestigator applied a gel (viscous lidocaine or Surgilube 
depending on randomization) to a cotton-tip applicator 
using a syringe to keep the amount consistent. Half of the 
gel was applied to the applicator. The applicator was then 
inserted into the designated nares until it met resistance and 
was left in place for 1 min. The applicator was then 
withdrawn, and a second applicator was then prepared and 
inserted the same way. The coinvestigator removed the 
second applicator after 1 min and left the room. The par- 
ticipants were unaware that one condition was a sham 
lubricant to reduce bias. The order of swallowing exami- 
nation and sensory examination was randomized for each 
participant. 
The principal investigator (PI) placed the sensory sheath 
(REF 444401, Medtronic Xomed, Jacksonville, FL, USA) 
over an ENTity endoscope (L0356A, length = 30 cm, 
width = 3.6 mm; Optim LLC, Sturbridge, MA, USA)) so 
that the air port in the sheath was in the 6 o’clock position 
on the endoscope, 180° away from the scope lever. A 
Stingray camera (09/17-285835485; Allied Vision 
Methods 
Participants 
The University of Central Arkansas Internal Review Board 
approved this research for human subjects. Participants were 
recruited from the University of Central Arkansas by word of 
mouth and IRB-approved flyers. A power analysis was 
completed a priori using G Power
© 
(v3.1.3); it was that
determined 30 participants were necessary to test the 
hypotheses. Forty-seven participants consented but 11 drop- 
ped out for the following reasons: nasal passages too narrow 
for scope passage (3), unwilling to attend second visit (6), 
vasovagal syncope (1), and voluntary discontinuation 
Swallowing Assessment Technologies, Stadtroda, Germany) recorded the images 
onto  NDOvision  software  (version  1.0)  installed 
MacBook Pro (Apple, Cupertino, CA, USA). 
on a 
Each participant drank 10 ± 1 and 20 ± 1 ml of cold 2 % 
milk (40–44 °F) from a medicine cup, three times for each 
amount, and a leveled teaspoon of room temperature 
applesauce three times, for a total of nine swallows per 
participant per condition. The order of swallows was 
always 10 ml milk, 20 ml milk, and the applesauce. The 
participant were instructed to hold the bolus in the mouth 
and swallow when instructed. A previous study reported 
that using a command to swallow does not alter the loca- 
tion of the bolus at the time of swallow initiation [43]. All 
swallows were recorded for later analysis and were 
reviewed in real time, slow motion, and frame by frame. 
The PI administered the examinations and analyzed all of 
the recordings blinded to condition. All recordings were 
given a random ID number to blind the examiner to the 
identity of the subject and condition. 
Sensory Testing 
Laryngeal Adductor Reflex (LAR) 
The LAR is a reflexive adduction of the vocal folds that 
occurs as a protective mechanism against aspiration [37]. It 
can be stimulated with air puffs applied to the aryepiglottic 
folds at rest. In our study, the AP-4000 (Vision Sciences, 
Inc., Orangeburg, NY, USA) was used to deliver the air 
puffs. It is a calibrated device that sends duration-con- 
trolled (50 ms) and pressure-controlled (0–10 mmHg) 
pulses of air down the length of an endoscope sheath 
through an internal port located within the sheath made 
especially for this purpose. A graduate research assistant 
sat next to the AP 4000 to adjust pulse delivery during the 
protocol. With the nasendoscope in place through the same 
nares to which gel was applied, air puffs were delivered to 
the aryepiglottic fold. The tip of the scope was held within 
2 mm of the tissue surface as described by Aviv and Murry 
[38]. 
LAR testing was always conducted prior to perceptual 
testing as it does not require the subject to give a response 
and allows the subject time to acclimate to the air puffs. It 
was conducted according to the protocol outlined by Aviv 
and Murray [38]. Air puff pressure began at 2.0 mmHg and 
increased in 0.5-mmHg increments until a LAR was elic- 
ited. Then pressure was decreased/increased in 0.1-mmHg 
increments until a threshold was established. The sensory 
threshold was determined after a positive LAR had been 
visualized three times. 
Previous research had established that the LAR thresh- 
Swallowing Measures Analyzed 
All swallows were analyzed for bolus dwell time and pha- 
ryngeal closure duration [44], as well as residue remaining 
after the swallow and penetration-aspiration scale (PAS) 
scores [11] (see Tables 1, 2, 3). 
Participant Comfort Scale 
Upon completion of the FEESST protocol, patients were 
asked to rate their comfort/discomfort by marking the 
intensity of sensation on a general-labeled magnitude scale 
[45]. The length of the vertical scale was 100 mm with the 
top labeled ‘‘Strongest sensation of any kind’’ and the 
bottom labeled ‘‘No sensation.’’ The mark was converted to 
a 0–100 score based on distance from the bottom (0). 
Also upon completion of the FEESST protocol, the 
endoscopic examiner (PI) rated the ease of passing the scope 
by marking a general-labeled magnitude scale [45]. The 
length of the vertical scale was 100 mm with the top labeled 
‘‘Most difficulty of any kind’’ and the bottom labeled ‘‘No 
difficulty.’’ The examiner also rated the quality of endo- 
scopic image obtained during the FEESST protocol by 
marking on a similar 100-mm general-labeled magnitude 
scale [45]. The top was labeled ‘‘Worst imaginable quality’’ 
and the bottom was labeled ‘‘No loss of image.’’ The marks 
were later converted to a 0–100 score based on distance 
from the bottom (0). 
old   is   comparable   to   the   laryngopharyngeal 
threshold [39]. 
sensory 
Participant Perception of Stimulus Intensity 
To determine the effect of TNA on sensory perception, a 
magnitude estimation sensory rating task was utilized [40]. 
Participants were instructed to rate the intensity of the air 
puff stimulation on a scale from 10 to 99 [41, 42]. If they 
felt the intensity was weak, they were to rate it with a lower 
number; if they felt the intensity was stronger, they were to 
rate it with a higher number. The intensities delivered 
included 2, 4, 6, 8, and 10 mmHg, and the order was 
randomized. Each intensity was delivered twice (for a total 
of 10 air puffs) to the aryepiglottic fold on the ipsilateral 
nares of the lidocaine/lubricant application. 
Analysis 
None of the swallowing measures, LAR thresholds, endo- 
scopic ease scores, or quality-of-view scores were normally 
Table 1  Swallowing duration measures 
Measure Start End 
Bolus dwell time at the vallecula (BDT-V) 
Bolus dwell time at the pyriform sinuses 
(BDT-P) 
Pharyngeal closure duration (PCD) 
First frame of bolus head approximation to the vallecula 
First frame of bolus head approximation to the 
pyriform sinus(es) 
First frame of complete whiteout 
First frame of complete whiteout 
First frame of complete whiteout 
Last frame of complete whiteout 
Table 2  Residue scale interclass correlation coefficient (ICC) to determine intrarater 
reliability; alphas ranged from 0.65 to 1.0. The lowest intrarater 
reliability score (a = 0.65) was from PAS scores for 10 ml and 
differed by only 1/42 swallowing PAS scores. Interrater reli- 
ability was also determined using ICC; alphas ranged from 0.52 
to 0.96, indicating moderate to strong agreement. 
Days between visit 1  and  visit  2  ranged  from  1  to 
23 days (m = 6.8). The number of days between visits did 





Absence of residue 
Residue coating or a trace amount of residue 
More than a coating, but less than 50 % of the bolus remains 
(moderate residue) 
3 More than 50 % of the bolus remains (severe residue) 
Vallecular residue and pyriform sinus residue were rated indepen- 
dently of each other 
Bolus Dwell Time at the Vallecula (BDT-V) 
and Pyriforms (BDT-P) 
Table 3 Penetration-aspiration scale 
Bolus dwell time at the valleculae (BDT-V) and pyriform 
sinuses (BDT-P) are FEES measures similar to stage 
transition duration on videofluoroscopy [44] and are 
defined as ‘‘the time duration in seconds from the first  
frame of bolus head approximation to the vallecula or the 
pyriform sinus(es) until the first frame of whiteout.’’ BDT 
values are provided in Tables 4, 5 and Fig. 1. 
A  significant  difference  was  found  between  the  two 
conditions for bolus dwell time at both the vallecula and 
pyriforms for 10-ml liquids only (p \ 0.05 for both loca- 
tions on Wilcoxon and t-tests). Examination of the means 
reveals that the anesthetized condition resulted in a faster 
initiated swallow than the sham condition for the 10-ml 
milk swallows. Significant differences in BDT between the 
lidocaine and sham conditions are not seen for 20-ml milk 
swallows or puree swallows on either statistical test. 
When examining the differences between bolus volumes 
within the experimental conditions, there was a significant 
difference between 10- and 20-ml milk swallows for BDT-V 
in the lidocaine condition only (p \ 0.05 for both statistical 
tests), indicating that when the participants had received 
lidocaine, the 20-ml boluses remained in the vallecula longer 
than the 10-ml boluses before the pharyngeal swallow ini- 
tiated (m = 0.05 vs. 0.02 s), but this difference was not seen 
in the sham condition. BDT did not significantly change as a 





No penetration or aspiration of material 
Laryngeal penetration of material 
Tracheal aspiration of material 
From Rosenbek et al. [11] 
distributed. Subject comfort scale scores and sensory per- 
ception ratings were normally distributed but represent 
ordinal data. Therefore, all data were analyzed first with the 
Wilcoxon signed-rank test and then with paired t-tests for 
comparison. Spearman’s rank order correlation was used 
for correlation analysis. 
Sensory perception data were analyzed using power 
functions, which were calculated by regressing log ratings 
on log intensity values using linear regression. Power 
functions are a log–log plot of the relationship between the 
physical intensity of sensory stimulation, in this case air 
puffs to the pharynx, and perception of stimulation inten- 
sity, specifically, the participant’s subjective rating. This 
relationship is summarized by the exponent and constant of 
the power function, with the exponent equal to the slope of 
the plotted function and the constant is the y-intercept. 
Changes in either the slope or the constant across condi- 
tions signal a change in perception of stimulation intensity. 
Results Pharyngeal Closure Duration (PCD) 
Twenty percent of swallowing measures were rescored by the 
original examiner and compared to the original analysis using 
Pharyngeal closure duration (PCD) was defined as ‘‘the 









Table 4 Bolus dwell times at the vallecula means and statistical tests 




























* Indicates significant finding
Table 5 Bolus dwell times at the pyriforms means and statistical tests 




























* Significant finding 
conditions. Residue scores were compared between bolus 
types, collapsing conditions and locations. Significant dif- 
ferences were found between 10- and 20-ml bolus residue 
scores (p \ 0.001), 10-ml liquid and puree bolus residue 
scores (p \ 0.01), and 20-ml liquid and puree bolus residue 
scores (p \ 0.001). Puree swallows resulted in the least res- 
idue (m = 0.76), followed by 10-ml swallows (m = 0.87) 
and 20-ml swallows (m = 1.05). 
When examined by visit order, pyriform residue was 
greater for swallows of 10 ml and puree during visit 1 
compared to visit 2 (p \ 0.05 for both bolus types). Val- 
lecular residue was not significant as a function of visit 
order. Fig. 1  Bolus  dwell  time 
* Significant at p \ 0.05
at  the  vallecula means  by condition. 
Penetration-Aspiration Scale (PAS) Scores 
complete whiteout.’’ There were no significant differences 
between the conditions for PCD for either liquid volume or 
the puree swallows for either statistical test. When com- 
paring bolus types, puree swallows showed a significantly 
shorter  PCD  than  both  10-  and  20-ml  liquid  swallows 
(m = 0.52 s vs. 0.59 and 0.62 s, respectively, p \ 0.001 
and p \ 0.001, respectively). This is true both within each 
condition and with the conditions collapsed. There was a 
significant difference between PCD for 10- and 20-ml liquid 
swallows only with conditions collapsed (p = 0.01). When 
examining visit order with conditions collapsed, participants 
swallowed faster on 10-ml swallows during their first visit 
than they did during the second visit (p \ 0.01 for both 
statistical tests). This is not observed for any other bolus 
type and is perhaps an anxiety effect as well as an order 
effect because 10 ml was always the first bolus swallowed. 
No significant differences were observed in PAS scores 
between lidocaine and sham conditions for any bolus type. 
Liquid swallow (10 and 20 ml) PAS scores ranged from 1 
to 8, indicating that penetration and aspiration occurred 
during certain liquid swallows. All puree swallows 
obtained a PAS score of 1, indicating that no penetration or 
aspiration occurred during any puree swallows. Collapsing 
conditions for 10-ml swallows, 203/216 (93.9 %) swallows 
resulted in a PAS score of 1, 12/216 (5.5 %) resulted in a 
PAS score associated with penetration (PAS scores 2–5), 
and 1/216 (0.5 %) resulted in a PAS score associated with 
aspiration (PAS scores 6–8). Collapsing conditions for 
20-ml swallows, 197/215 (91.6 %) swallows received a 
PAS score  of 1, 15/215  (6.9 %)  received  a PAS score 
associated with penetration, and 3/215 (1.4 %) received a 
PAS score associated with aspiration. Significant differ- 
ences were observed between puree PAS scores and 10-ml 
liquid PAS scores (m = 1.0 vs. 1.14, p \ 0.005 for both 
statistical tests) and 20-ml liquid PAS scores (m = 1.0 vs. 
1.25,   p \ 0.001   for   both   statistical   tests),   with   the 
Residue Scales 
There were no significant differences in residue severity in 
the  vallecula  or  pyriforms  between  lidocaine  and  sham 
 
 
conditions collapsed, but there was no significant differ- 
ence between 10-ml PAS scores and 20-ml PAS scores 
(p = 0.16). PAS scores did not differ between visits. 
(m = 48 vs. 49.47, respectively; p = 0.74) (Fig. 2). There 
was no correlation between comfort rating and the length 
of the exam for either the TNA condition (p = 0.12) or the 
sham condition (p = 0.08). Comfort ratings did not differ 
between visits (visit 1: m = 49.66;  visit  2: m = 47.8; 
p = 0.9), indicating that prior experience with nasendos- 
copy did not change the participants’ subjective measure of 
discomfort. 
Laryngeal Adductor Reflex (LAR) 
All means under both conditions fell well within the range 
of ‘‘normal’’ laryngeal sensation [12]. No significant dif- 
ference was found for LAR thresholds between the lido- 
caine and sham conditions (m = 2.11 vs. 2.05 mmHg, 
respectively; p = 0.18). 
Lidocaine did not improve the participants’ ability to 
tolerate laryngopharyngeal sensory testing. Two of the 36 
participants were not able to tolerate sensory testing during 
either condition, while 1 during the lidocaine condition and 
2 in  the sham  condition  were  also  not able  to tolerate 
Clinician Examination Scales 
Endoscopic ease and quality of view were rated on a 0-100 
general-label magnitude scale. There was no significant 
difference between the two conditions for endoscopic ease 
utilizing the Wilcoxon (p = 0.19) or the t test (p = 0.51) 
(Fig. 2). Endoscopic ease was significantly better during 
visit 2 (m = 11.75) compared to visit 1 (m = 15.36), with 
conditions collapsed using the Wilcoxon (p \ 0.05) but not 
the t-test (p = 0.12). 
Likewise, there was no significant difference between 
the two conditions for quality of view when using either the 
Wilcoxon (p = 0.68) or the t-test (p = 0.64). Quality of 
view did not differ between visits 1 and 2 (m = 20.19 vs. 
18.83 respectively; p = 0.5). 
sensory testing. LAR thresholds 
visits. 
did not differ between 
Sensory Perception Task 
Results were analyzed using power functions, which allow 
for the examination of the relationship between objectively 
measurable stimuli and the corresponding subjective assess- 
ment of those stimuli made by the participants. To determine 
the effects of anesthesia on laryngopharyngeal sensory per- 
ception, all sensory perception data were log10 transformed 
and the coefficient of determinations (r
2
), constant means, 
and exponent means were calculated as a measure of accu- 
racy of the relationship between the actual values (air puff 
pressure) and the participants’ estimation (sensory percep- 
tion) of those values. No significant difference was observed 
for the sensory perception task r
2
, constant, or exponent 
values between the  lidocaine  and  the  sham  condition 
(p = 0.81, 0.72, and 0.91, respectively). 
More participants were unable to tolerate the laryngo- 
pharyngeal sensory perception task than the LAR threshold 
task. During the course of the study, the sensory perception 
task was discontinued 13 of 72 times. Four of the 36 par- 
ticipants were not able to tolerate the sensory perception 
task in either the lidocaine or the sham condition, 2 were 
unable to tolerate the task during the lidocaine condition, 




did not differ between visits, an 
indication that there was no learning effect. More partici- 
pants asked that the sensory perception task be stopped 
during visit 2 (8/36) than during visit 1 (5/36). 
Exam Length 
Endoscopic examination time, which includes all endoscopic 
procedures, ranged from 7.37 to 19.2 min (m = 13.09 min). 
The higher examination times are within normal limits for a 
FEESST exam [46]. The mean duration of the exam for the 
lidocaine and sham conditions was 13.33 and 12.99 min, 
respectively. There was no significant difference between 
length of exam for the two conditions using the Wilcoxon 
(p = 0.53) or the t-test (p = 0.70). There was a significant 
difference  in  exam  length  between  visit  1  and  visit  2 
Participant Comfort Ratings 
No  significant  difference  was  found  for  comfort  scale 
means  between  the  lidocaine  and  the  sham  condition Fig. 2  Scale rating means by condition 
(p \ 0.01). Endoscopic exams were significantly longer for 
visit 1 than for visit 2 (m = 14.25 vs. 12.06 min, respec- 
tively). There was a slight correlation between quality-of- 
view scores and exam length for the lidocaine condition 
(r = 0.50), indicating that the poorer the view, the longer the 
exam took. 
When using FEES in an inpatient medical setting, however, 
gel TNA is likely easier since it does not require an 
atomizer with disposable covers. Moreover, since the 
introduction of FEES [3], the official protocol, still used by 
clinicians around the world, is to apply gel TNA using the 
cotton tip applicator, partly because of the likelihood of a 
nasal spray anesthetizing the laryngopharynx. Our findings, 
compared with the findings of Butler et al. [28], support 
this assumption. 
The only significant difference observed in this study as 
the result of anesthesia was a faster bolus dwell time (or 
faster stage transition) for 10-ml liquid swallows in the 
lidocaine condition. It is unclear why these swallows would 
be initiated faster in the anesthetized condition, but this 
trend is not observed for any other bolus size or type. It 
might be reasonable to point out that while the cause is 
uncertain, the result is not a detrimental one. Essentially, 
the use of lidocaine gel did not delay the initiation of the 
pharyngeal swallow, and in this respect the swallows with 
TNA are just as safe as those without. Other significant 
findings unrelated to the experimental conditions were 
observed for 10-ml liquid swallows, including shorter 
pharyngeal closure duration and increased residue during 
the first visit compared to the second visit, independent of 
the experimental condition. It is possible that these three 
effects for 10 ml occurred as a result of the order of bolus 
type, as this was not randomized. Ten-milliliter liquid 
swallows were always the first taken during the swallowing 
portion of the FEESST exam. Interestingly, the shorter 
pharyngeal closure times and increased residue scores were 
not significantly correlated. Thus, shorter pharyngeal con- 
traction times did not result in increased severity of pha- 
ryngeal residue. 
Bolus dwell times differ from those previously reported 
in the literature. Butler et al. [44] used FEES with 10-ml 
boluses and reported maximum dwell times of 2.75 and 
2.67 s in the vallecula and pyriforms, respectively, com- 
pared to 0.50 and 0.37 s reported in this study. Similarly, 
Dua et al. [48] reported bolus dwell times of 3.2 and 1.4 s, 
though it was unclear whether they were reporting means 
or maximum times. Differences in methods and the age 
range of participants are possible explanations for the 
discrepancies. Butler et al. [44] included both young and 
older normal participants in the data reported, and age has 
been found to significantly increase bolus dwell time and 
pharyngeal delay time  [44, 49]. In Butler’s study [44], 
syringes were used to administer the boluses, while in 
Dua’s study [48] self-feeding in a natural mealtime envi- 
ronment was used. Other studies using VFSS have reported 
pharyngeal delay times of 0.12 s [50] and -0.18 s [49] in 
younger normal participants, although the definition of 
pharyngeal delay time can vary. Dua et al. [48] reported 
that liquid was seen in or past the vallecula before swallow 
Discussion 
Effects of TNA on Swallowing 
Results of this study indicate that 0.4 ml of 2 % gel lidocaine 
applied to the nares unilaterally with a cotton-tip applicator 
did not affect swallowing physiology or laryngopharyngeal 
sensation. However, the results of this study do not support 
using gel TNA to improve patient comfort or ease and the 
speed of the examination. The amount of lidocaine used in 
this study is based on the Langmore protocol for FEES, 
suggesting two placements of the cotton-tip applicator in the 
nares, each for 1 min. The amount may seem small at 0.4 ml, 
but this is the maximum amount of gel that can be applied by 
the prescribed method. Another study that used 1 ml of 4 % 
lidocaine spray reported significant findings for both 
increased PAS scores and patient comfort ratings [28], and it 
is likely that the increased volume and concentration of the 
anesthesia and the method of administration are responsible 
for the difference in findings compared to the present study. 
It can be presumed that the gel anesthesia used in this study 
did not drip into the pharynx; or, if it did, it was too small an 
amount to cause alterations to the swallow physiology. 
It is possible that the anesthesia could have affected 
more proximal structures such as the tongue base and soft 
palate, and as FEESST directly tests only for the laryngeal 
adductor reflex, these transient changes in sensation would 
not be quantified. It can be conjectured, however, that if the 
tongue base was exposed to sufficient anesthesia to alter 
the swallow, the functional consequence would be 
increased residual, particularly in the vallecula [2]. How- 
ever, there was no increase in pharyngeal residue second- 
ary to TNA observed in this study. The majority of 
swallows resulted in a residue score of 1 for all consis- 
tencies and volumes, denoting a trace amount of residue or 
a residue coating. This amount of residue is considered 
normal, as it requires two consecutive swallows to clear a 
bolus, which was also observed in this study but not 
quantified [18, 47]. Therefore, it can be hypothesized that 
either the anesthesia did not drip on the tongue base or if it 
did, it was not a sufficient amount to alter the motor 
function and bolus clearance. 
It is reasonable to suggest that application of anesthesia 
in otolaryngology offices is done primarily by using 
atomizers to spray the  anesthesia into  the  nasal  cavity. 
initiation in 60 % of participants during a natural mealtime, 
which is even more than the 22 % reported in this study. 
The use of TNA also did not alter pharyngeal closure 
durations in this study. Since pharyngeal closure duration is 
measured from the first frame of whiteout to the last frame 
of whiteout, it is essentially measuring the duration of 
pharyngeal contraction against the tongue base for bolus 
propulsion. Lack of sensory input has an effect on pha- 
ryngeal duration as demonstrated by Mansson and Sand- 
berg [51], who reported that extensive anesthetizing of the 
oropharynx resulted in significantly prolonged pharyngeal 
contraction. This again validates that the nasal anesthesia 
did not anesthetize the pharynx in this experiment. The 
PCD means reported in this study are similar to those 
reported previously for healthy participants [18, 44]. Of 
note, PCD increased as volumes increased, with 5-ml puree 
having the shortest times and 20-ml liquid having the 
longest times, with 10-ml liquid falling in between. This 
volume effect has been previously reported in the literature 
[18]. 
The PAS scores reported in this study are also similar to 
those reported in other studies using FEES. Butler et al. 
[44] reported penetration and aspiration rates of 0.5 % each 
for healthy participant swallows, whereas Jafari et al. [25] 
described a 2 % incidence of penetration and 0 % aspira- 
tion. This investigation yielded penetration and aspiration 
rates of 5.5 and 0.5 %, respectively. Complete anestheti- 
zation of the swallowing mechanism  results in a much 
higher incidence of unsafe swallows, with 43 % of swal- 
lows penetrated and 24 % aspirated [25]. 
were introduced to minimize discomfort, such as neck 
extension or humming while the scope was lowered. This 
study’s participants were young (mean age = 23.6 years), 
and it is possible that they were more sensitive to supra- 
glottic trespass than the healthy participants in the Aviv 
et al. study who were slightly older (mean age = 34 years) 
[16, 52]. It may also be considered that if a patient cannot 
tolerate FEESST secondary to coughing and gagging 
because of the supraglottic presence of the scope, their 
supraglottic sensation for the purposes of swallowing 
should be adequate. 
Effects of TNA on Rating Scales 
Nasal anesthesia did not improve the ease of scope 
advancement through the nasal passageways either. The 
endoscopic ease ratings were, on average, quite low on the 
0–100 scale, indicating relative ease of scope passage, and 
they are comparable to ratings reported by Cain et al. [29] 
who used cophenylcaine. Notably, there was a difference in 
endoscopic ease ratings comparing means across visits, 
indicating that the examiner found endoscope insertion to be 
generally easier during the second visit. This is perhaps due 
to the familiarity with each participant’s nasal anatomy, 
having already navigated it once. Similarly, exam length 
was found to be shorter during visit 2, although exam length 
and endoscopic ease were not correlated, indicating that the 
visit 2 exams were not shorter because the endoscopic 
insertion was easier. It is possible that the visit 2 exam 
length was shorter because each participant knew what to 
expect and required less direction to complete the tasks. 
Quality of view during the exam did not differ between 
the two experimental conditions. Essentially, the lidocaine 
did not obscure the lens any more than the lubricant; and, 
again, the means reported in this study are comparable to 
those reported by Cain [29], which are low on the 0–100 
scale. Similarly, TNA did not improve participant comfort 
ratings, which indicates that the amount and concentration 
used in this study was not entirely effective in numbing the 
nares against the feeling of the endoscope. Pain/comfort 
ratings for previous investigations on nasal anesthesia range 
from 5 to 40 for the TNA condition and from 8 to 57 for the 
placebo/no treatment condition [20, 27, 29, 32, 33]. With 
means of 48 and 49.47, respectively, the comfort rating 
means reported in this study are comparable to previous 
comfort rating means, if not slightly on the higher end. 
Effects of TNA on Sensation 
In  addition  to  TNA  having  no  detrimental 
swallowing  physiology,  there  were  also  no 
effects  on 
effects  on 
laryngopharyngeal sensory thresholds or sensory percep- 
tion. What was interesting about the FEESST portion of the 
study was the number of participants who could not tol- 
erate the sensory testing, which requires the participant to 
inhibit coughing or swallowing while the endoscope is 
advanced past the epiglottis and held approximately 2 mm 
from the arytenoid cartilage or aryepiglottic fold in order to 
deliver the calibrated burst of air. Fourteen percent of the 
participants were not able to tolerate the LAR threshold 
testing and 25 % of the participants were not able to tol- 
erate the sensory perception testing at some point during 
the study. Aviv et al. [16, 52] reported that 100 % of 
healthy participants and 96.5 % of patients were able to 
tolerate FEESST, though the reason for discontinuation of 
the 3.5 % of patients was not given. The participants in our 
study for whom sensory testing was discontinued experi- 
enced increased coughing and gagging when the scope was 
introduced into the supraglottic region, even after strategies 
Summary 
The most clinically significant finding from this study is 
that TNA, applied in gel form directly to the nares, did not 
delay  onset  of  the  pharyngeal  swallow  or  otherwise 
increase the participants’ risk of penetration or aspiration 
of the test materials during the FEES exam. However, it is 
important to keep in mind that the number of participants 
included in this study was small (36) and gives this study 
low statistical power, thus increasing the risk of a type II  
error. Butler et al. [28] reported increased PAS scores after 
administration of spray TNA. It can be surmised that the 
amount and concentration of spray used in the Butler study 
[28] was suprathreshold to altering the sensory and/or 
motor aspects of the swallow resulting in a less safe 
swallow, but was also suprathreshold to improving patient 
comfort and tolerance during the procedure. Although the 
amount and concentration used in this study did not alter 
the safety of the swallows, it was also not effective in 
improving participant comfort, which contradicts the pri- 
mary purpose of its use. Future studies should evaluate 
older normal participants and patients with dysphagia and 
should account for the various factors of TNA, including 
concentration, dosage amount, and method of application, 
to determine the optimal strategy for providing comfort 
while avoiding altered swallowing. Cain et al. [29] reported 
a correlation between pre-examination anxiety and pain 
scores, whereas Singh et al. [34] reported a correlation 
between deviated nasal septum and pain scores. Future 
studies may find that patients with high anxiety scores as 
well as those with narrow nasal passageways are the 
patients that benefit most from receiving TNA. 
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